IRIS
COVRE, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.963
EU - Europa 1.408
AS - Asia 218
OC - Oceania 4
AF - Africa 2
SA - Sud America 2
Totale 3.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.956
IE - Irlanda 434
IT - Italia 311
GB - Regno Unito 159
RU - Federazione Russa 142
SE - Svezia 118
CN - Cina 100
FR - Francia 78
UA - Ucraina 64
SG - Singapore 52
VN - Vietnam 45
DE - Germania 37
ES - Italia 28
FI - Finlandia 28
CA - Canada 5
AU - Australia 3
IN - India 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
HK - Hong Kong 2
IL - Israele 2
PA - Panama 2
PH - Filippine 2
TR - Turchia 2
ZA - Sudafrica 2
BE - Belgio 1
BO - Bolivia 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 3.597
Salva come PNG Salva come JPEG
Città #
Dublin 432
Fairfield 386
Ashburn 178
Woodbridge 176
Seattle 166
Cambridge 147
Houston 144
Wilmington 139
Southend 132
New York 66
Princeton 64
Jacksonville 62
Siena 62
Shanghai 45
Dong Ket 43
Ann Arbor 42
Singapore 36
San Mateo 33
Chandler 30
San Diego 29
Málaga 28
Rome 27
Helsinki 25
Beijing 24
Dearborn 20
Milan 19
Florence 17
Fremont 15
Moscow 15
London 12
Palermo 12
Santa Clara 10
Empoli 8
Guangzhou 6
Montevarchi 6
Asciano 5
Labico 5
Padova 5
Redwood City 5
San Giovanni Valdarno 5
Toronto 5
Trieste 5
Boardman 4
Catania 4
San Francisco 4
Altamura 3
Ascoli Piceno 3
Lappeenranta 3
Lavis 3
Norwalk 3
Novara 3
Phoenix 3
Abu Dhabi 2
Carmignano 2
Chiswick 2
Chiusdino 2
Ferentino 2
Gavirate 2
Hefei 2
Hong Kong 2
Hounslow 2
Livorno 2
Nanjing 2
Pistoia 2
Pontedera 2
Salerno 2
Sesto Fiorentino 2
Stockholm 2
Tel Aviv 2
Torino 2
Udine 2
Warsaw 2
Washington 2
Amman 1
Arienzo 1
Arlington 1
Athens 1
Auckland 1
Bagno a Ripoli 1
Baku 1
Baotou 1
Bari 1
Berlin 1
Bishkek 1
Bologna 1
Brisbane 1
Brussels 1
Cascina 1
Centurion 1
Chicago 1
Colombo 1
Dallas 1
Figline Valdarno 1
Fuzhou 1
Guiyang 1
Islington 1
Johannesburg 1
Kilburn 1
Lambeth 1
Lisbon 1
Totale 2.793
Salva come PNG Salva come JPEG
Nome #
Immunomodulatory properties of DNA hypomethylating agents: Selecting the optimal epigenetic partner for cancer immunotherapy 155
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016 143
Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial 129
The biology of cancer testis antigens: putative function, regulation and therapeutic potential 127
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival 126
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy 120
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017 117
“Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013 116
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma 114
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications 103
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies 103
Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models 101
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 99
Immunotherapy targeting immune check-point(s) in brain metastases 97
Molecular pathways: At the crossroads of cancer epigenetics and immunotherapy 97
Epigenetically‐Regulated Therapeutic Tumor‐Associated Antigens 93
Epigenetically-regulated Tumor-Associated Antigens in melanoma 92
Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications 92
Whole genome methylation profiles as independent markers of survival in stage IIIc melanoma patients 91
null 87
Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients 85
Prognostic Potential of Integrated Whole Genome Methylation and Expression Profiling in Cutaneous Melanoma 82
Epigenetics meets immune checkpoints 79
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 78
null 75
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story 74
Challenges in lung cancer therapy during the COVID-19 pandemic 69
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era 68
Epigenetic immune remodeling of mesothelioma cells: A new strategy to improve the efficacy of immunotherapy 65
Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status 62
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications 62
Cancer testis antigens and melanoma stem cells: new promises for therapeutic intervention. 59
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study 57
null 56
Immunomodulatory activity of SGI-110, a 5-aza-2 '-deoxycytidine-containing demethylating dinucleotide 53
A novel microRNA signature for the detection of melanoma by liquid biopsy 49
Epigenetics of melanoma: implications for immune-based therapies. Immunotherapy, 5:1103-1116, 2013 48
COVID and Lung Cancer 42
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 41
Primary analysis and 4-year follow-up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases 39
Immunotherapy of brain metastases: breaking a "dogma" 37
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial 35
Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy 35
A phase Ib study combining the second-generation DNA hypomethylating agent (DHA) guadecitabine (SGI-110) and ipilimumab in patients with metastatic melanoma: the NIBIT-M4 Study. 35
The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma 31
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology 30
Safety and immunobiological activity of guadecitabine sequenced with ipilimumab in metastatic melanoma patients: The phase Ib NIBIT-M4 study 30
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 29
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study 26
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 21
Totale 3.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020984 0 0 0 98 137 121 144 158 129 88 35 74
2020/2021841 24 90 57 102 92 86 38 122 32 71 31 96
2021/2022417 12 56 37 7 8 29 19 17 27 52 60 93
2022/2023514 47 37 100 46 11 91 18 31 44 31 41 17
2023/2024769 35 20 75 28 21 212 244 26 27 12 26 43
2024/2025229 57 40 132 0 0 0 0 0 0 0 0 0
Totale 3.754